Articles Archives
Articles
05/26/2026
Dominic Clarke on Reducing Variability Before it Becomes a Problem
As cell therapy programs advance, the pressure on supply chains doesn’t usually come from a single breaking point. It builds gradually, often in ways that aren’t immediately visible during early development. In a recent episode of Beyond Biotech, the podcast from Labiotech, Dominic Clarke, Vice President of IntegriCell® Technical Operations at Cryoport Systems, shares what that progression looks like.
Articles
05/26/2026
Cryoport Systems in Labiotech on Where CGT Supply Chains Start to Break
As more cell and gene therapy programs push toward later-stage trials and commercialization, a familiar set of pressures is starting to surface. What once felt manageable at smaller scale begins to take more effort to hold together as volumes pick up. A recent article in Labiotech, developed in collaboration with Cryoport Systems, looks closely at where that strain comes from and how it often traces back to decisions made much earlier in development.
Articles
05/26/2026
Cryoport Systems with ISCT on Why Early-Phase Development is Starting to Strain
As advanced therapy programs move faster toward first-in-human (FIH), the pressure isn’t just showing up at commercial scale. It’s appearing much earlier than many teams expect. A recent article Cryoport Systems published with ISCT takes a closer look at that shift, highlighting why execution (not feasibility) is increasingly becoming the constraint in early development.
Articles
05/26/2026
Matthew Plaud on Building Supply Chains that Actually Scale
In a recent conversation with Contract Pharma, Matthew Plaud, COO of IntegriCell® at Cryoport Systems, discussed where advanced therapy supply chains stand today, and where they start to strain as programs move toward commercialization.
Articles
03/18/2026
Cryoport Systems Honored at the Asia Pacific Biopharma Excellence Awards
Cryoport Systems is pleased to announce that we have been awarded Best Logistics & Supply Chain Management Supplier – Digital Technology & Software at the Asia Pacific Biopharma Excellence Awards 2026, held March 11 in Singapore. This recognition reflects both the progress of our organization and the growing importance of dependable, technology-driven support in the development and delivery of advanced therapies across the region.
Articles
01/27/2026
Embracing Digital Excellence with Transition to Digital Shipping Instructions
Cryoport Systems is thrilled to announce the official transition from printed shipping instructions to digital, QR code-based instructions. This move strengthens our commitment to sustainability and operational excellence while providing a streamlined user experience. This change reflects a natural evolution in how life sciences organizations access and standardize critical shipping information, and we’re excited to bring these enhancements to our global client community.
Articles
11/17/2025
Cryoport Systems Named Finalist in Four Categories at Asia-Pacific Biopharma Excellence Awards 2026
Cryoport Systems has been named a finalist in four categories for the upcoming Asia-Pacific Biopharma Excellence Awards 2026. These nominations reflect our unwavering commitment to innovation and excellence in supporting the global biopharma community.
Articles
11/07/2025
Cryoport Systems Wins “BioServices Innovation of the Year” for Safepak® Soft System 1800
Cryoport Systems is proud to announce that our Safepak® Soft System 1800 has been named BioServices Innovation of the Year by the prestigious BioTech Breakthrough Awards program. This recognition highlights our continued commitment to advancing cryogenic logistics for cell and gene therapy developers through innovation and excellence when it comes to safety and sustainability.
Articles
10/30/2025